This preview shows pages 1–2. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: Intro Background (+) Problem (+) Ideal Screening Criteria (+) Current Methods Biomarkers (CA19-9) (Argo) Proposed Method When Who Risk Factors Symptoms Pancreatic Cancer is the fourth leading cause of death in the United States, with a survival rate of less than 5 percent in 5 years. No reliable screening methods exist to help detect this deadly cancer in humans. Current statistics show that about 42470 people are diagnoses with this disease but only about 35240 people die from the disease. (1)The National Cancer Institute asked our team, to investigate and evaluate current methods for pancreatic cancer, including the effectiveness of the most commonly used methods. Consecutively, recommendations regarding potential future screening strategies were also included. It is essential to detect pancreatic cancer in the earlier stages as possible, so the pancreatic cancer can be stopped before it spreads throughout the body. Due to the relatively low incidence rate, efforts are focused on early detection and screening in patients at high risk. relatively low incidence rate, efforts are focused on early detection and screening in patients at high risk....
View Full Document
- Spring '10